Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HZA114971: Fluticasone furoate 50 mcg once daily and growth velocity in prepubertal children with asthma
2016-002551-22Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Fluticasone furoate 50 mcg OD with Placebo OD (2 arms). Primary endpoint: Growth velocity over one-year double-blind treatment. Started Nov 2016; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2016-002551-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002551-22.